Gan & Lee Pharmaceuticals, a Chinese bio-pharmaceutical company backed by Qiming Venture Partners and other investors, is seeking a domestic IPO to raise RMB1.5 billion (US$221 million) two years after its first attempt failed.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?